VitroScan

Private

LeidenHealthcare & Life Scienceshttps://vitroscan.com/

Last Round

Health Holland

Grant

May 26, 2026

Total Funding Raised

$5.31M

Company Overview

VitroScan is a biotechnology company that provides a 3D micro-tumor testing platform designed to support precision treatment development for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

precision oncologyex vivo testingtumor organoidspredictive diagnostic assaydrug sensitivity testingpersonalized cancer therapy3D cell cultureclinical trial de-riskingcancer drug discoverypredictive analyticspatient-derived modelsorgan-on-a-chipbiotech service provider

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VitroScan Comparables

Compare VitroScan with similar companies based on industry and business-model similarity.

VitroScan comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

VitroScan Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Health Holland Grant	May 26, 2026
Grant	Apr 22, 2025
Grant	Dec 2, 2024
Grant	Sep 5, 2023
Grant	Aug 23, 2022
Grant	Aug 15, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Willemijn Vader

CEO

Executive Team

VitroScan Investors

Notable investors and investment history

VitroScan investors
Investor	Rounds
KWF Dutch Cancer Society	Grant
EIT Health	Grant
Eurostars SME programme	Grant
Libertatis Ergo Holding	Seed
medical:forge Leipzig	Grant
Health~Holland	Health Holland Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 11, 2019
$901K round with Libertatis Ergo Holding and Pieter Geelen.

View all signals

VitroScan Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

VitroScan Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VitroScan's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeiden

Employee Range10

Year Founded2016

Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.